Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 50,793	$ 19,264
Restricted cash, current	478	503
Short-term investments	27,416	54,194
Financial assets:
Accounts receivable	8,757	11,920
Contract assets	492	4,375
Unbilled receivables	1,480	2,751
Total financial assets	10,729	19,046
Less: allowances	(43)	(162)
Total financial assets, net	10,686	18,884
Inventories	1,817	1,799
Prepaid expenses and other current assets	5,626	4,128
Total current assets	96,816	98,772
Restricted cash	1,612	1,062
Investment in non-marketable equity securities	2,498	2,798
Right-of-use assets - Operating leases, net	30,501	28,700
Property and equipment, net	13,024	14,197
Goodwill	2,463	2,463
Other non-current assets	883	1,019
Total assets	147,797	149,011
Current liabilities:
Accounts payable	1,554	2,838
Accrued compensation	11,042	11,410
Other accrued liabilities	2,768	6,223
Current portion of lease obligations - Operating leases	2,944	2,827
Deferred revenue	7,009	350
Total current liabilities	25,317	23,648
Deferred revenue, net of current portion	360	100
Long-term lease obligations - Operating leases	30,159	28,163
Long-term debt	40,105	28,905
Other long-term liabilities	1,327	1,268
Total liabilities	97,268	82,084
Commitments and contingencies (Note 13)
Stockholders’ equity:
Preferred stock, $0.0001 par value per share; 5,000 shares authorized, none issued and outstanding	0	0
Common stock, $0.0001 par value per share; 200,000 shares authorized; 90,478 and 81,850 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively	9	8
Additional paid-in capital	657,292	629,673
Accumulated other comprehensive income	8	52
Accumulated deficit	(606,780)	(562,806)
Total stockholders’ equity	50,529	66,927
Total liabilities and stockholders’ equity	$ 147,797	$ 149,011